MAIA Biotechnology, Inc. (MAIA) Form 10-Q Quarterly Reports
MAIA Biotechnology, Inc. (MAIA) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MAIA
CIK: 1878313
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grant Thornton LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerJoseph Heatherly
Audit LocationCharlotte, North Carolina, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 424B3 | 2026-10-07 | — | 424B3 | 0001493152-26-046059 | View SEC Doc Filr Page |
| EFFECT | 2026-10-06 | — | EFFECT Filing | 9999999995-26-003161 | View SEC Doc Filr Page |
| 8-K | 2026-10-06 | 2026-10-06 | 8-K | 0001493152-26-045865 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | PRIMARY DOCUMENT | 0001878313-26-000100 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | PRIMARY DOCUMENT | 0001878313-26-000099 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | PRIMARY DOCUMENT | 0001878313-26-000098 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | PRIMARY DOCUMENT | 0001878313-26-000097 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | PRIMARY DOCUMENT | 0001878313-26-000096 | View SEC Doc Filr Page |
| 424B3 | 2026-10-02 | — | 424B3 | 0001493152-26-045521 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | PRIMARY DOCUMENT | 0001878313-26-000095 | View SEC Doc Filr Page |
| S-3 | 2026-09-25 | — | S-3 | 0001493152-26-044361 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-14 | PRIMARY DOCUMENT | 0001878313-26-000087 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | PRIMARY DOCUMENT | 0001878313-26-000084 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-26 | PRIMARY DOCUMENT | 0001878313-26-000082 | View SEC Doc Filr Page |
| EFFECT | 2026-08-28 | — | EFFECT Filing | 9999999995-26-002814 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | PRIMARY DOCUMENT | 0001878313-26-000079 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-20 | PRIMARY DOCUMENT | 0001878313-26-000077 | View SEC Doc Filr Page |
| S-3 | 2026-08-21 | — | S-3 | 0001493152-26-039679 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001604867-26-000014 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | 10-Q | 0001493152-26-036764 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | PRIMARY DOCUMENT | 0001878313-26-000074 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | PRIMARY DOCUMENT | 0001878313-26-000073 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | PRIMARY DOCUMENT | 0001878313-26-000072 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | PRIMARY DOCUMENT | 0001878313-26-000071 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | PRIMARY DOCUMENT | 0001878313-26-000070 | View SEC Doc Filr Page |